Maravai LifeSciences

Update in progress

MRVI (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Maravai LifeSciences Holdings, Inc. is a San Diego–based life sciences company that provides products and services used to develop drugs, vaccines, cell and gene therapies, and diagnostics worldwide. It operates two segments: TRILINK, which supplies nucleic acid reagents, oligonucleotides, mRNA tools, enzyme development, and related research products; and CYGNUS, which offers analytical assays, antibody and assay development, impurity and viral clearance kits, and related services.

Company score

Sentiment: -0.51; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.62; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.46; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.28; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.40; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive